newsfilter
← Latest News
ACCESS Newswire·

Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs

SAN DIEGO, CA / ACCESS Newswire / September 14, 2026 / Ensysce Biosciences, Inc. a clinical-stage biotechnology company developing novel neuroplastogenic